Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

8.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Tumor Progression02:07

Tumor Progression

3.7K
3.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

856
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
856

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stakeholders' Attitudes on Automating Data Abstraction in a Surgical Quality Improvement Program.

Joint Commission journal on quality and patient safety·2026
Same author

Veteran perspectives on dialysis modality and vascular access communication in the United States veterans health administration: A qualitative study.

Preventive medicine reports·2026
Same author

American College of Surgeons Verification Programs: Do We Need Standard Measures or Should We Really Be Measuring Standards?

Journal of the American College of Surgeons·2026
Same author

BPI26-015: Complementing NCCN Guidelines With a Clinician-Guided AI Reasoning Platform: Evaluation of The BlueScrubs.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

BPI26-015: Complementing NCCN Guidelines With a Clinician-Guided AI Reasoning Platform: Evaluation of The BlueScrubs.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Neoadjuvant Chemoradiation Versus Chemotherapy for Esophageal Cancer: A Histology-Stratified Update Meta-Analysis of Randomized Controlled Trials.

Annals of surgical oncology·2026

Related Experiment Video

Updated: Apr 19, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

881

Soft tissue sarcomas: staging principles and prognostic nomograms.

Nader N Massarweh1, Paxton V Dickson, Daniel A Anaya

  • 1VA HSR&D Center for Innovations in Quality, Effectiveness and Safety, Michael E DeBakey VA Medical Center, Houston, Texas; Michael E DeBakey Department of Surgery, Division of Surgical Oncology, Baylor College of Medicine, Houston, Texas.

Journal of Surgical Oncology
|December 9, 2014
PubMed
Summary
This summary is machine-generated.

Soft tissue sarcomas (STS) present management challenges. This review discusses limitations in current STS staging and explores future directions for pre-operative staging and predictive nomograms.

Keywords:
nomogramsprognostic factorssoft tissue sarcomastaging

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K

Related Experiment Videos

Last Updated: Apr 19, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

881
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

1.0K
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

10.5K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Staging

Background:

  • Soft tissue sarcomas (STS) are rare, heterogeneous tumors posing significant management difficulties.
  • Current treatment and staging rely on the American Joint Committee on Cancer (AJCC) system.
  • Existing staging methods have limitations in accurately guiding STS management.

Purpose of the Study:

  • To critically evaluate the limitations of the current STS staging system.
  • To explore potential future directions for pre-operative staging of STS.
  • To discuss the utility of predictive nomograms in addressing knowledge gaps in STS management.

Main Methods:

  • Review of current literature on soft tissue sarcoma staging.
  • Analysis of the American Joint Committee on Cancer (AJCC) staging system for STS.
  • Discussion of predictive nomograms and their role in oncology.

Main Results:

  • The current AJCC staging system for STS has inherent limitations.
  • Pre-operative staging requires further refinement for improved patient outcomes.
  • Predictive nomograms show promise in enhancing prognostic accuracy and guiding treatment decisions.

Conclusions:

  • There is a need to address the limitations of current STS staging systems.
  • Advancements in pre-operative staging and the use of predictive nomograms are crucial for improving STS patient care.
  • Further research is warranted to develop and validate novel staging and predictive tools for soft tissue sarcomas.